Computational Integration to Model Tumor Dynamics in CLL Patients Treated with the Btk Inhibitor Ibrutinib (CompuTreatCLL): First Results of an Integrative Systems Biology Approach

Référence

Loic Ysebaert, Sarah Cadot, Salim Kanoun, Soleakhena Ken, Christian Recher, François Malgouyres, Sébastien Gadat, Loïc Dupré et Anne Quillet Mary, « Computational Integration to Model Tumor Dynamics in CLL Patients Treated with the Btk Inhibitor Ibrutinib (CompuTreatCLL): First Results of an Integrative Systems Biology Approach », Blood, vol. 130, n° 1, 2017.